Skip to content. | Skip to navigation


Personal tools

Leigha Rock, PhD


lrock@bccrc.ca  675 West 10th Avenue, Vancouver, B.C., V5Z 1L3, Canada

| BCCA | BCCRC | Integrative Oncology | Cancer Genetics | Wan Lam LabLeigha Rock, PhD
 
Leigha


Program

  • Post-Doctoral Fellow, BC Cancer Research Centre
 

Education and Training

  • DipDH, College of New Caledonia
  • BDSc, University of British Columbia 
  • PhD (Craniofacial Science), University of British Columbia  


Credentials

  • RDH, CDHBC (Full Registration, 365-day exempt)

Research Interests

  • molecular epidemiology
  • oral cancer biology 
  • histopathogical imaging
  • population health science 
  • gene expression 
  • tumour microenvironment 
  • risk stratification for oral dysplasia

Selected Scholarships and Awards

  • Pfizer Research Innovation Fund (2018-2020)
  • CIHR Frederick Banting and Charles Best Canada Graduate Scholarship (CGS-D) (2016-2018)
  • CIHR Institute of Cancer Research Travel Award (2017)
  • Killam Graduate Teaching Assistant Prize, Office of the Provost and Vice-President Academic, University of British Columbia (2017) 
  • Graduate Teaching Assistant Award, Faculty of Dentistry, the University of British Columbia (2015, 2016, 2017, 2018)
  • AADR Student Research Day Award (2017)
  • UBC Faculty of Dentistry Research Day Poster Competition, PhD Student Award (2017)
  • CDHA/ Hu-Friedy Nevi 2.0 Scholarship, Master's/Doctorate Level (2016)
  • Alpha Omega Foundation 
  • Four Year Doctoral Fellowship, the University of British Columbia (2015)
  • CDHA National Conference Student Travel Award (2015)
  • UBC GSS Travel Award (2015)
  • UBC Faculty of Dentistry Travel Award (2015)
  • UBC Faculty of Dentistry Research Day Competition, Senior Undergraduate Clinical Student Award (2015)
  • R.E. McKechnie Graduate Scholarship, Faculty of Graduate and Postdoctoral Studies, the University of British Columbia (2014)
  • Dr. S. Wah Leung Scholarship, Faculty of Dentistry, the University of British Columbia (2014)
  • BC OCPP Graduate Clinical Research Award, British Columbia Cancer Foundation (2014)
  • Joan Voris Award of Achievement, Faculty of Dentistry, the University of British Columbia (2014)
  • Bessie Diamond Memorial Scholarship, the University of British Columbia (2013) 
  • Dean's List Academic Achievement, Faculty of Dentistry, the University of British Columbia (2012, 2013, 2014)

Publications

  • Zhang L, Rock LD, Rosin MP, Laronde DM. Lichenoid mucositis - the chicken or the egg? J Dent Res. 2018 Sep;97(10):1179.

  • Rock LD, Laronde DM, Lin I, Rosin MP, Chan B, Shariati B, Zhang L. Dysplasia should not be ignored in lichenoid mucositis. J Dent Res. 2018 Jul;97(7):767-772.

  • Rock LD, Rosin MP, Zhang L. Chan B, Shariati B, Laronde DM. Characterization of epithelial oral dysplasia in non-smokers: First steps towards precision medicine. Oral Oncology. 2018;97:119-125. 
  • Maraschin BJ, Silva VP, Rock L, Sun H, Visioli F, Rados PV, Rosin MP. Optimizing fixation protocols to improve molecular analysis from FFPE tissues. Braz Dent J. 2017 Jan-Feb;28(1):82-84.
  • Rock LD, Tkatch EA, Laronde DM. Oral cancer screening: dental hygienists' responsibility, scope of practice and referral pathway. Can J Dent Hyg 2014;48(1):42.46.
  • Rock L. Potential of platelet rich fibrin in regenerative periodontal therapy: literature review. Can J Dent Hyg 2013;47(1):33-37.

Selected Conference Abstracts and Presentations

  • Gutkind JS, Ondrey F, Laronde DM, Rosin MP, Molinolo A, Coffey C, Wertz B, Rock LD, Huynh H, Chow H-H, Butler V, Lippman S, Szabo E. M4OC-Prevent: Clinical evaluation of metformin for oral cancer precision prevention. Cancer Research 2018; In: Proceeding of the AACR Conference. Abstract 4985; Chicago, IL, (2018).
  • Lin I, Laronde DM, Zhang L, Rosin MP, Chan B, Rock LD. Oral Lichenoid dysplasia - at risk of malignant progression. J Dent Res. 2018;97(A):1694. In: Proceedings of the AADR Conference, Fort Lauderdale, FL (2018).
  • Rock LD, Rosin MP, Zhang L, Shariati B, Laronde DM. Non-smokers with oral epithelial dysplasia posses higher risk of malignant progression. In: Proceedings of the Canadian Cancer Research Conference. Abstract CRP-22, Vancouver, BC (2017).
  • Rock LD, Rosin MP, Zhang L, Shariati B, Laronde DM. Characterization of epithelial oral dysplasia in non-smokers: Working towards precision medicine. Cancer Research. 2017;77(13 Supplement):3265. In: proceedings of the AACR Annual Meeting, Washington, DC (2017).
  • Rock LD, Rosin MP, Zhang L, Shariati B, Laronde DM. Molecular and clinical features of low-grade dysplasia in never smokers. J Dent Res. 2017;96(A):1161. In: Proceedings of the IADR/AADR/CADR General Session, San Francisco, CA(2017).
  • Rosin MP, Laronde D, Zhang L, MacAulay C, Chan B, Rock L, Auluck A, Corbett K. Developing anew framework to improve outcome of oral cancer: vision, application and scale-up.UICC World Cancer Congress;2016 Oct; Paris, France (2016). 
  • Rock LD, Rosin MP, Zhang L, Shariati B, Laronde DM. Molecular analysis and changes in toluidine blue over time: predicting malignant progression. J Dent Res. 2016;95(A):1729. In: Proceedings of the AADR General Session, Los Angeles, CA (2016). 
  • Rock LD, Rosin MP, Zhang L, Laronde DM. Can clinicopathological feathers of low-grade oral dysplasia with high-risk molecular patterns predict malignant progression? Can J Dent Hyg. 2015;49(3):128. In: Proceedings of the CDHA National Conference, Victoria, BC (2015).
  • Rock LD, Zhang L, Rosin MP, Laronde DM. Toluidine blue stain variation and malignant progression of oral dysplasia. J Dent Res. 2015; 94(A): 2720. In: Proceedings of the IADR/AADR/CADR General Session, Boston MA (2015).

 Invited Talks

  • "Oral cancer research: Dental hygienists are making a difference". Invited Oral Presentation. UBC Faculty of Dentistry Dental Hygiene Alumni CE and Reception; Vancouver, BC. (2017) 
  • "Molecular and clinical features of low-grade dysplasia in never smokers". Oral Presentation. IADR/AADR/CADR General Session and Exhibition; San Francisco, CA. (2017)
  • Molecular analysis and changes in toluidine blue over time - predicting malignant progression". Invited Oral Presentation. UBC Faculty of Dentistry Research Day; Vancouver,BC. (2016)
  • "Can clinicopathological features of low-grade dysplasia with high-risk molecular patterns predict malignant progression? Oral Presentation. CDHA National Conference, Victoria, BC. (2015)

Press Releases 


Links

| BCCA | BCCRC | Integrative Oncology | Cancer Genetics | Wan Lam Lab |